Intraperitoneal chemotherapy

Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer
Sarah E Taylor, Jennifer S Petschauer, Heidi Donovan, Allison Schorzman, Juan Razo, William C Zamboni, Robert P Edwards, Kristin K Zorn

International Journal of Gynecologic Cancer Jan 2019, 29 (1) 147-152; DOI: 10.1136/ijgc-2018-000055
Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer
Michelle Davis, Emeline Aviki, J. Alejandro Rauh-Hain, Michael Worley, Ross Berkowitz, John Schorge, Michael Muto, Rachel Clark Sisodia, Neil Horowitz, Marcela del Carmen

International Journal of Gynecologic Cancer Jul 2016, 26 (6) 1033-1040; DOI: 10.1097/IGC.0000000000000729
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer
Michelle M. Boisen, Jamie L. Lesnock, Scott D. Richard, Sushil Beriwal, Joseph L. Kelley, Kristin K. Zorn, Robert P. Edwards

International Journal of Gynecologic Cancer May 2016, 26 (4) 626-631; DOI: 10.1097/IGC.0000000000000667
Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer
Rudy S. Suidan, Qin Zhou, Alexia Iasonos, Roisin E. O’Cearbhaill, Dennis S. Chi, Kara C. Long Roche, Edward J. Tanner, John Denesopolis, Richard R. Barakat, Oliver Zivanovic

International Journal of Gynecologic Cancer May 2015, 25 (4) 599-606; DOI: 10.1097/IGC.0000000000000389
Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?: An Exploratory Analysis
Nashmia Joudallah Al Mutairi, Tien Le

International Journal of Gynecologic Cancer Mar 2014, 24 (3) 461-467; DOI: 10.1097/IGC.0000000000000066
Debulking Surgery and Intraperitoneal Chemotherapy Are Associated With Decreased Morbidity in Women Receiving Neoadjuvant Chemotherapy for Ovarian Cancer
William Robinson, Evelyn Cantillo

International Journal of Gynecologic Cancer Jan 2014, 24 (1) 43-47; DOI: 10.1097/IGC.0000000000000009
Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer: Feasibility, Compliance, and Complications
Pierluigi Benedetti-Panici, Giorgia Perniola, Claudia Marchetti, Milena Pernice, Cristina Donfrancesco, Violante Di Donato, Federica Tomao, Innocenza Palaia, Marialida Graziano, Stefano Basile, Filippo Bellati

International Journal of Gynecologic Cancer Jul 2012, 22 (6) 1069-1074; DOI: 10.1097/IGC.0b013e31825736b2
Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
Luca Ansaloni, Vanni Agnoletti, Andrea Amadori, Fausto Catena, Davide Cavaliere, Federico Coccolini, Pierandrea De Iaco, Monica Di Battista, Massimo Framarini, Filippo Gazzotti, Claudio Ghermandi, Barbara Kopf, Maristella Saponara, Francesca Tauceri, Carlo Vallicelli, Giorgio Maria Verdecchia, Antonio Daniele Pinna

International Journal of Gynecologic Cancer Jun 2012, 22 (5) 778-785; DOI: 10.1097/IGC.0b013e31824d836c
Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes
Malgorzata E. Skaznik-Wikiel, Jamie L. Lesnock, William C. McBee, Sushil Beriwal, Kristin K. Zorn, Scott D. Richard, Thomas C. Krivak, Robert P. Edwards

International Journal of Gynecologic Cancer Feb 2012, 22 (2) 232-237; DOI: 10.1097/IGC.0b013e318234f833
Extraperitoneal Metastases From Recurrent Ovarian Cancer
William R. Robinson, Julie Beyer, Stephen Griffin, Paiyarut Kanjanavaikoon

International Journal of Gynecologic Cancer Jan 2012, 22 (1) 43-46; DOI: 10.1097/IGC.0b013e31823532ce

Main menu

Intraperitoneal chemotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Intraperitoneal chemotherapy

Pages